[1]
P. Pfeiffer, D. Nielsen, M. Yilmaz, A. Iversen, C. Vejlø, and B. Vittrup Jensen, “Cetuximab and irinotecan as third line therapy in patients with advanced colorectal cancer after failure of irinotecan, oxaliplatin and 5-fluorouracil”, AO, vol. 46, no. 5, pp. 697–701, Jan. 2007.